Clinical Trials List
Protocol NumberEPI-326-001
Not yet recruiting
2026-09-01 - 2029-10-19
Phase I
Not yet recruiting2
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Tsung-Jang Yeh Division of Hematology & Oncology
- 許瑞峰 Division of Hematology & Oncology
- 王閔宏 Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
- 謝子禹 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
110 participants
